Lipofen

Lipofen is a brand name of fenofibrate, approved by the FDA in the following formulation(s):

LIPOFEN (fenofibrate - capsule; oral)

• 
  Manufacturer: CIPHER PHARMS INC
  
  Approval date: January 11, 2006
  
  Strength(s): 150MG ^[RLD], 50MG
  

Has a generic version of Lipofen been approved?

No. There is currently no therapeutically equivalent version of Lipofen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lipofen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical composition containing fenofibrate
  Patent 5,545,628
  Issued: August 13, 1996
  Inventor(s): Deboeck; Arthur & Maes; Paul & Baudier; Phillipe R.
  Assignee(s): Galephar P.R. Inc.
  A pharmaceutical composition is provided for treating hyperlipidemia or hypercholesterolemia or both in a mammal, which contains an effective amount of each of fenofibrate and an excipient containing one or more polyglycolyzed glycerides.
  
  Patent expiration dates:
  
  
  • January 10, 2015
    
    ✓ 
    Patent use: TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR HYPERTRIGLYCERIDEMIA
    ✓ 
    Drug product
  
  

See also...

• Lipofen Consumer Information (Wolters Kluwer)
• Lipofen Consumer Information (Cerner Multum)
• Lipofen Advanced Consumer Information (Micromedex)
• Fenofibrate Consumer Information (Drugs.com)
• CIP - Fenofibrate Consumer Information (Wolters Kluwer)
• Fenofibrate Consumer Information (Wolters Kluwer)
• Fenofibrate Consumer Information (Cerner Multum)
• Fenofibrate Advanced Consumer Information (Micromedex)
• Fenofibrate AHFS DI Monographs (ASHP)